☆ 4.7 Article

Hybrids of carbonic anhydrase and cyclooxygenase inhibitors attenuate cardiac hypoxic inflammatory injuries

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

An Original Aspirin-Containing Carbonic Anhydrase 9 Inhibitor Overcomes Hypoxia-Induced Drug Resistance to Enhance the Efficacy of Myocardial Protection

Wen Zhou et al.

Summary: The overexpression of CAIX in myocardial cells is closely related to drug resistance in myocardial ischemia injury. A novel CAIX inhibitor, AcAs, has been developed to overcome acquired drug resistance and more effectively attenuate myocardial ischemia and hypoxia injury than aspirin. CAIX inhibitor shows great potential for further application in myocardial hypoxia injury therapy.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

A hypoxia-activated NO donor for the treatment of myocardial hypoxia injury

Wen Zhou et al.

Summary: In this study, a novel hypoxia-activated NO donor (Hano) was designed and prepared, which can increase NO release, dilate blood vessels, and attenuate myocardial hypoxia injury. This drug shows great potential for the treatment of hypoxic heart diseases.

CHEMICAL SCIENCE (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Targeting cardiovascular inflammation: next steps in clinical translation

Patrick R. Lawler et al.

Summary: Systemic vascular inflammation plays crucial roles in the progression and destabilization of ASCVD, requiring more individualized approaches for successful clinical translation. High-sensitivity C-reactive protein may serve as a clinical measure of inflammation.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Inflammation and cardiovascular diseases: lessons from seminal clinical trials

Luca Liberale et al.

Summary: Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) and Colchicine Cardiovascular Outcomes Trial (COLCOT) were the first two randomized clinical trials to demonstrate the effectiveness of specific anti-inflammatory treatments in cardiovascular prevention, confirming the involvement of specific inflammatory pathways in atherosclerotic cardiovascular disease. Other trials targeting multiple inflammasome-independent pathways failed to show benefit, highlighting the significance of balancing the risk of impaired host defense and infections with the prevention of major adverse cardiovascular events in patients with residual inflammatory risk.

CARDIOVASCULAR RESEARCH (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Metabolic inflammation in heart failure with preserved ejection fraction

Gabriele G. Schiattarella et al.

Summary: HFpEF is a common chronic cardiovascular disease, where metabolic disturbance and inflammatory burden play important roles in its pathogenesis. The interplay between these two processes is complex, with metabolic inflammation having a central role in shaping the pathophysiology of HFpEF.

CARDIOVASCULAR RESEARCH (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Cyclooxygenases and the cardiovascular system

Jane A. Mitchell et al.

Summary: COX-1 and COX-2 enzymes play crucial roles within the cardiovascular system through different pathways regulating thrombus formation. Drug inhibition of COX is important for therapeutic intervention and manifestation of side effects.

PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease

Antonio Pelliccia et al.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors

Saberio Lo Presti et al.

Summary: Recurrent pericarditis (RP) is a complex inflammatory disorder with unknown etiology, but IL-1 inhibitors have emerged as a treatment option with beneficial clinical outcomes.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Interplay between inflammation and thrombosis in cardiovascular pathology

Konstantin Stark et al.

Summary: Thrombosis is a major health challenge globally, with inflammation playing a crucial role in driving thrombotic diseases. Anti-inflammatory strategies show promise in targeting cardiovascular pathologies and addressing therapeutic gaps.

NATURE REVIEWS CARDIOLOGY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Emerging role of carbonic anhydrase inhibitors

Claudiu T. Supuran

Summary: Inhibition of carbonic anhydrase has been used clinically for various applications including treating glaucoma, epilepsy, obesity, and cancer. Recent studies have discovered new roles of CA isoforms in areas like pain management, Alzheimer's disease, and oxidative stress, leading to potential novel clinical applications. Additionally, inhibition of CA in pathogenic microorganisms is being explored for new anti-infective drugs.

CLINICAL SCIENCE (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Modulation of microRNAs by aspirin in cardiovascular disease

Maryam Paseban et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2020)

添加到收藏夹

Article Chemistry, Medicinal

Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis

Silvia Bua et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Review Immunology

Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review

Homa Nomani et al.

INFLAMMOPHARMACOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association

Salim S. Virani et al.

CIRCULATION (2020)

添加到收藏夹

Review Chemistry, Multidisciplinary

Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review

Rashmi Kumari et al.

JOURNAL OF CONTROLLED RELEASE (2020)

添加到收藏夹

Review Cell Biology

Cellular adaptation to hypoxia through hypoxia inducible factors and beyond

Pearl Lee et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment

Dan M. Roden et al.

CIRCULATION (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

Antonio Abbate et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Obesity, Hypertension, and Cardiac Dysfunction Novel Roles of Immunometabolism in Macrophage Activation and Inflammation

Alan J. Mouton et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Rapamycin restrains platelet procoagulant responses via FKBP-mediated protection of mitochondrial integrity

Kamila M. Sledz et al.

BIOCHEMICAL PHARMACOLOGY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective

Samik Bindu et al.

BIOCHEMICAL PHARMACOLOGY (2020)

添加到收藏夹

Review Chemistry, Medicinal

Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?

Chandra B. Mishra et al.

MEDICINAL RESEARCH REVIEWS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions

Alaa A. -M. Abdel-Aziz et al.

BIOORGANIC CHEMISTRY (2019)

添加到收藏夹

Review Microbiology

Drug combinations: a strategy to extend the life of antibiotics in the 21 st century

Mike Tyers et al.

NATURE REVIEWS MICROBIOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hypoxia signaling in human diseases and therapeutic targets

Jae W. Lee et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

A novel ferulic acid derivative attenuates myocardial cell hypoxia reoxygenation injury through a succinate dehydrogenase dependent antioxidant mechanism

Fei Wang et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

添加到收藏夹

Article Chemistry, Analytical

Smart Plasmonic Nanorobot for Real-Time Monitoring Cytochrome c Release and Cell Acidification in Apoptosis during Electrostimulation

Guohua Qi et al.

ANALYTICAL CHEMISTRY (2019)

添加到收藏夹

Review Computer Science, Interdisciplinary Applications

Deep learning for healthcare applications based on physiological signals: A review

Oliver Faust et al.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

J. J. McNeil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors

Claudiu T. Supuran

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Thrombospondins: A Role in Cardiovascular Disease

Dimitry A. Chistiakov et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

添加到收藏夹

Review Immunology

Regulation of immunity and inflammation by hypoxia in immunological niches

Cormac T. Taylor et al.

NATURE REVIEWS IMMUNOLOGY (2017)

添加到收藏夹

Review Cell Biology

Physiological and Pharmacological Control of BAK, BAX, and Beyond

Mark P. A. Luna-Vargas et al.

TRENDS IN CELL BIOLOGY (2016)

添加到收藏夹

Review Chemistry, Medicinal

Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis

Nicholas Schwier et al.

PHARMACEUTICALS (2016)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.